Overview
A rapid, accurate diagnosis is essential for emergency care professionals to improve outcomes and manage resources in high-volume Emergency Departments (EDs.) Join this exclusive webinar with a global expert presenting one of the first real-world reports on implementing a point-of-care, high-sensitivity cardiac troponin I (hs-cTnI) assay in a busy ED.
Webinar Highlights
- Real-World Evidence: Learn from the ICare-FASTER initiative, where the Atellica VTLi hs-cTnI assay was introduced into multiple New Zealand EDs using a stepped-wedge approach. Experience how integrating POC hs-cTnI into an accelerated diagnostic pathway for possible acute coronary syndrome significantly reduced patient length of stay compared to traditional lab testing.
- Practical Guidance: Get actionable advice on embedding POC hs-cTnI testing into your clinical environment, addressing common operational and clinical challenges.
- Expert Insights: Benefit from the expertise of Professor Martin Than, a leading authority on cardiac biomarkers, who will share evidence-based recommendations.
- Live Q&A: Engage with Prof. Than for real-time discussion on implementation, outcomes, and best practices.
Who Should Attend?
- Emergency Medicine Physicians
- Laboratory Personnel
- Cardiologists
- Nurses
Speaker Information
Dr. Martin Than
Director, Emergency Medicine Research, Christchurch Hospital, New Zealand
Dr. Martin Than is the Director of Emergency Medicine Research, an Emergency Medicine specialist at Christchurch Hospital in New Zealand, and Honorary Professor of Medicine at the University of Otago. His research is centered on quality improvement initiatives for the emergency department, focusing on cardiac biomarkers. Dr. Than is the principal investigator on the ICare-FASTER interventional study, which assessed implementation of a point-of-care hs-cTnI assay compared to a central hs-cTnI laboratory assay and the impact on patient length of stay in the Emergency Department.